On the recordMarch 1, 2017
Some brand drug manufacturers are using REMS programs to delay competition
Source
congress.govSome brand drug manufacturers are using REMS programs to delay competition
Pallone highlights misuse of REMS by brand manufacturers to hinder generics.
Share
More from Frank Pallone
I knew it was not going to go well, but I didn't know it was going to be this bad.
I’m glad I was able to secure the federal funding necessary to support this project, which will make these Jersey Shore communities more resilient in the years to come.
Whether it's the hospitals, the doctors, the nurse, they're really trying to care for people.
We had no choice but to introduce the arbitration system if we wanted to actually get rid of surprise billing.